Ontology highlight
ABSTRACT: Objective
1,5 anhydroglucitol (1,5 AG) is emerging as a marker of short-term glycemic control. We measured levels of 1,5 AG, fructosamine (FA), and glycated hemoglobin (HbA1c) in Asian Indians with different degrees of glucose intolerance.Materials and methods
We recruited 210 individuals with normal glucose tolerance (NGT; n = 60), impaired glucose tolerance (IGT; n = 50), and Type 2 diabetes mellitus (T2DM; n = 100) from a large tertiary diabetes center in Chennai in Southern India. Anthropometric measurements were obtained using standardized techniques. Serum 1,5 AG (enzymatic colorimetric assay), FA (NBT/kinetic), and HbA1c (high-performance liquid chromatography) estimations were performed.Results
1,5 AG levels were significantly lower in the T2DM followed by IGT compared with the NGT group (7.9 vs. 18.8 vs. 21.8 µg/ml, P < 0.05). FA and HbA1c were higher in T2DM and IGT compared with NGT individuals (313 vs. 237 vs. 200 µmol/L, P < 0.001) (8.3 vs. 5.8 vs. 5.3%, P < 0.001).1,5 AG showed a significant negative correlation with FA (r = -0.618, P < 0.001) and HbA1c (r = -0.700, P < 0.001). 1,5 AG decreased with increasing quartiles of postprandial glucose (P for trend <0.001). However, even among individuals with HbA1c ?7%, 27% individuals had decreased 1,5 AG plasma level (<10 µg/ml).Conclusion
Circulatory levels of 1,5 AG correlate negatively with FA and HbA1c, and may provide an additional marker to assess glycemic control in patients with Type 2 diabetes.
SUBMITTER: Pramodkumar TA
PROVIDER: S-EPMC5040052 | biostudies-literature | 2016 Sep-Oct
REPOSITORIES: biostudies-literature
Indian journal of endocrinology and metabolism 20160901 5
<h4>Objective</h4>1,5 anhydroglucitol (1,5 AG) is emerging as a marker of short-term glycemic control. We measured levels of 1,5 AG, fructosamine (FA), and glycated hemoglobin (HbA1c) in Asian Indians with different degrees of glucose intolerance.<h4>Materials and methods</h4>We recruited 210 individuals with normal glucose tolerance (NGT; <i>n</i> = 60), impaired glucose tolerance (IGT; <i>n</i> = 50), and Type 2 diabetes mellitus (T2DM; <i>n</i> = 100) from a large tertiary diabetes center in ...[more]